A former paramedic, Dr. Steven Therialt earned a PhD in molecular genetics and virology, spending 15 years working on projects like the Ebola vaccine at the National Microbiology Lab. Now as CEO of Cytophage Technologies Inc., he’s looking for a solution to the antibiotic resistance crisis, and has identified one in bacteriophages, viruses that destroy harmful bacteria. He’ll share how these natural predators can be put to use as targeted warriors in the battle against superbugs.